Onward Medical N.V. - Asset Resilience Ratio

Latest as of June 2024: 16.01%

Onward Medical N.V. (ONWD) has an Asset Resilience Ratio of 16.01% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€7.50 Million

≈ $8.77 Million USD Cash + Short-term Investments

Total Assets

€46.85 Million

≈ $54.78 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2022)

This chart shows how Onward Medical N.V.'s Asset Resilience Ratio has changed over time. See Onward Medical N.V. financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down Onward Medical N.V.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Onward Medical N.V..

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€7.50 Million	16.01%
Total Liquid Assets	€7.50 Million	16.01%

Asset Resilience Insights

Good Liquidity Position: Onward Medical N.V. maintains a healthy 16.01% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Onward Medical N.V. Industry Peers by Asset Resilience Ratio

Compare Onward Medical N.V.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Onward Medical N.V. (2022–2022)

The table below shows the annual Asset Resilience Ratio data for Onward Medical N.V..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	26.11%	€20.00 Million ≈ $23.38 Million	€76.59 Million ≈ $89.55 Million	--

pp = percentage points

About Onward Medical N.V.

BR:ONWD Belgium Biotechnology

Market Cap

$189.80 Million

€162.35 Million EUR

Market Cap Rank

#16684 Global

#71 in Belgium

Share Price

€2.34

Change (1 day)

+0.21%

52-Week Range

€2.33 - €5.52

All Time High

€12.90